VeClose Five Year Follow-Up Extension Study

CompletedOBSERVATIONAL
Enrollment

114

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

January 31, 2019

Study Completion Date

January 31, 2019

Conditions
Great Saphenous Vein (GSV) With Venous Reflux Disease
Interventions
DEVICE

VenaSeal SCS

Non-tumescent, non-thermal, non-sclerosant procedure that uses a proprietary medical adhesive delivered endovenously to close the vein.

DEVICE

ClosureFast Radiofrequency Ablation (RFA)

Radiofrequency thermal ablation of the GSV using the Covidien ClosureFast system.

DEVICE

Roll-In (VenaSeal SCS)

Non-tumescent, non-thermal, non-sclerosant procedure that uses a proprietary medical adhesive delivered endovenously to close the vein.

Trial Locations (9)

14120

Vein Institute of Buffalo, North Tonawanda

21030

MD Laser Skin & Vein Institute, Hunt Valley

23452

Sentara Vascular Specialists, Virginia Beach

62701

Prairie Education & Research Cooperative, Springfield

80111

Radiology Imaging Associates (RIA), Greenwood Village

85255

Morrison Vein Institute, Scottsdale

92121

GBK Cosmetic Laser Dermatology, San Diego

97701

Inovia Vein Speciality Center, Bend

98004

Lake Washington Vascular, Bellevue

Sponsors
All Listed Sponsors
lead

Medtronic Endovascular

INDUSTRY

NCT03455699 - VeClose Five Year Follow-Up Extension Study | Biotech Hunter | Biotech Hunter